Sue Yom
3 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Nivolumab + Chemoradiation in Stage II-IVB Nasopharyngeal Carcinoma (NPC) (NCT03267498) | Sue Yom | 2018-02-14 |
| Pembrolizumab With and Without Radiotherapy for Non-Small Cell Lung Cancer (NCT03217071) | Sue Yom | 2017-10-04 |
Track Sue Yom automatically
Every clearance here is in the API, with alerts when new ones post.